Loading…
This event has ended. Visit the official site or create your own event on Sched.

View analytic
Tuesday, June 28 • 4:00pm - 5:00pm
#278: Real Life Application of Risk-Based Monitoring

Sign up or log in to save this to your schedule and see who's attending!

Limited Capacity seats available

Component Type: Workshop
Level: Intermediate

This session will include a facilitated discussion about common application experiences applied through case-based learning and will encourage audience members to share similar or different experiences in their risk-based monitoring implementations.

**Due to session format, seating will be limited to 50 participants and available on a first come, first served basis. Once all seats are occupied, DIA will be required to close the session, and no more participants will be admitted. Interested attendees are encouraged to arrive early in order to ensure seating.

Learning Objectives

Explain how to apply the implementation lessons of risk-based monitoring to your own situation.

Chair

Brett Wilson

Speaker

Facilitator
Lisa Horne-Lucero, BSN

Facilitator
Kate Owen



Chair
avatar for Brett Wilson

Brett Wilson

Head, Monitoring Excellence, Bristol-Myers Squibb Company
Brett Wilson, BSP, is Head of Monitoring Excellence at Bristol-Myers Squibb and leads both Risk Based Monitoring and eSource initiatives with TransCelerate BioPharma. Within BMS, Brett is responsible for ensuring an accountable and sustainable adaptive monitoring model focused on the support of people and process, tools and technology and monitoring effectiveness.

Speakers
avatar for Lisa Horne-Lucero

Lisa Horne-Lucero

Consultant, RBM Operations, Clinical Risk Management, Eli Lilly and Company
Lisa is an RBM Operations Consultant in Eli Lilly’s Clinical Risk Management organization. She develops and implements RBM processes, procedures and training as she guides study teams through the RBM implementation process. She has been a key leader in the implementation of RBM at Lilly since its inception. She also continues to serve as a site monitoring subject matter expert for the business.
avatar for Kate Owen

Kate Owen

Vice President, Clinical Trial Management, Novo Nordisk Inc.
Kate is the Vice President of Clinical Trial Management at Novo Nordisk (Princeton, NJ) with 22 years’ experience within the biotech, pharmaceutical and CRO space. Her leadership has led to improved productivity, cost-effectiveness, quality and staff morale. She sponsors the Novo Nordisk RBM project endorsed late in 2015 & is now responsible for the implementation, adaptation & change management across the organization globally.


Tuesday June 28, 2016 4:00pm - 5:00pm
Exhibit Hall A Pennsylvania Convention Center 1101 Arch Street, Philadelphia, PA 19107 USA